MELINDA ANAMDI: Open Payments
NPI 1710122817 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 38 payments from 11 companies in 2025. Trend: 2023 $60 · 2024 $422 · 2025 $909
Food & beverage: $853Education: $56
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 16 | $347 |
| Regeneron Healthcare Solutions, Inc. | 7 | $206 |
| Optinose US, Inc. | 6 | $114 |
| Smith+Nephew, Inc. | 1 | $59 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $37 |
| Itamar Medical Inc | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| GENZYME CORPORATION | 1 | $24 |
| Amgen Inc. | 1 | $22 |
| Medtronic, Inc. | 1 | $21 |
Products named: NUCALA, DUPIXENT, Xhance, TULA, TEZSPIRE, NEFFY, WatchPATONE, PROPEL.
Industry payments across FL — which companies pay providers there.
